Perikatan Nasional secretary-general Azmin Ali has described a reported offer for BN components MCA and MIC to join the opposition pact as a “positive development” towards the next 16th general ...
Four members of Oregon’s congressional delegation are among the 50 federal lawmakers who signed a letter on Friday demanding answers after the arrest of two crew members fighting the Bear Gulch fire ...
You don’t need a prompt engineering certificate to use AI in your job search. What you need is a starting prompt template, and we’ve got you covered. In earlier articles, we explored what not to do ...
The Pittsburgh Pirates are calling up infielder Cam Devanney from Triple-A Indianapolis ahead of Saturday's game against the Boston Red Sox. The move, first reported by Jose Negron of DK Pittsburgh ...
Sarah Geronimo and husband Matteo Guidicelli are the latest celebrities to express their frustration with alleged corruption in government contracts linked to undelivered flood control projects of the ...
Liverpool signing Alexander Isak once snubbed Cristiano Ronaldo’s attempt to get him to join Real Madrid with a phone call. Liverpool finally managed to land Isak on transfer deadline day this week by ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
JM Financial upgrades Inox Wind target price to Rs 158 Execution expected to improve from Q3 supported by new CERC circular Rights issue of INR 12.5 billion completed to boost financial strength In ...
Human Rights Watch (HRW) on Monday called on Ethiopian authorities to take action to address a wave of improper detentions, stating that security forces have arbitrarily arrested several journalists ...
Legal experts say families could now be looking to sue the drugmaker Kenvue after the Trump administration linked the use of acetaminophen in pregnancy to autism. Senate Minority Leader Schumer says ...
The FDA approved imlunestrant for treatment of certain adults with breast cancer who experience disease progression after at least one prior line of endocrine therapy.